公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2002 | Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 142 | 138 | |
2015 | On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy | YI-WEN HUANG ; Takahashi S.; Tsuge M.; CHI-LING CHEN ; Wang T.-C.; Abe H.; Hu J.-T.; DING-SHINN CHEN ; Yang S.-S.; Chayama K.; JIA-HORNG KAO | Antiviral Therapy | 61 | 57 | |
2007 | OncoDB.HCC: An integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci | Su W.-H.; Chao C.-C.; Shiou-Hwei Yeh ; DING-SHINN CHEN ; PEI-JER CHEN ; Jou Y.-S. | Nucleic Acids Research | 86 | 78 | |
1999 | Opportunistic hepatic infections in aids patients with fever of unknown origin | Chang Y.-G.; PEI-JER CHEN ; CHIEN-CHING HUNG ; Chen M.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 4 | |
2004 | Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation | CHUN-JEN LIU ; JIA-HORNG KAO ; HURNG-YI WANG ; Lai M.-Y.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 17 | 17 | |
1983 | An outbreak of hepatitis A in junior college students verified by IgM hepatitis A antibody testing. | DING-SHINN CHEN ; Sung J.L.; Lai M.Y.; PEI-MING YANG ; Lin J.T.; Chuang J.N.; Chen J.S. | Journal of the Formosan Medical Association | 5 | 0 | |
2006 | Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen T.-C.; Lin F.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of Viral Hepatitis | 14 | 12 | |
1994 | Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: Different roles for the small and large delta antigens | Wang H.-W.; PEI-JER CHEN ; Lee, Cha-Ze ; Wu H.L.; DING-SHINN CHEN | Journal of Virology | 38 | 37 | |
1988 | Pancreatic carcinoma associated with chronic calcifying pancreatitis in Taiwan: a case report and review of the literature | Lin, J T; Wang, T H; DING-SHINN CHEN ; How, S W; Lai, M Y; Chen, J C; Sung, J L | Pancreas | 12 | 13 | |
2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
2004 | Patient Data, Early SARS Epidemic, Taiwan | PO-REN HSUEH ; PEI-JER CHEN ; Hsiao C.-H.; Yeh S.-H.; WERN-CHERNG CHENG ; Wang J.-L.; BOR-LUEN CHIANG ; SHAN-CHWEN CHANG ; Chang F.-Y.; Wong W.-W.; CHUAN-LIANG KAO ; PAN-CHYR YANG ; DING-SHINN CHEN ; Lee Y.-T.; Teng C.-M.; HONG-NERNG HO ; MING-FU CHANG ; Wang J.-T.; Wang W.-K. | Emerging Infectious Diseases | 65 | 54 | |
2007 | Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6] | CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | New England Journal of Medicine | 1 | 1 | |
2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
2015 | Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Huang C.-F; JOU-WEI LIN ; Dai C.-Y; Liang C.-C; Huang J.-F; Hung P.-H; Tsai H.-B; MENG-KUN TSAI ; CHIH-YUAN LEE ; Chen S.-I; Yang S.-S; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang W.-L; Yu M.-L; JIA-HORNG KAO | Gut | 36 | 30 | |
2015 | Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study | CHEN-HUA LIU ; WANG-HUEI SHENG ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Lo Y.-C; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Liu W.-C; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Scientific Reports | 13 | 12 | |
2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
2014 | Peginterferon α in the treatment of chronic hepatitis B | TAI-CHUNG TSENG ; JIA-HORNG KAO ; DING-SHINN CHEN | Expert Opinion on Biological Therapy | 19 | 17 | |
2016 | Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway | Liu W.-L.; HUNG-CHIH YANG ; Hsu C.-S; Wang C.-C; Wang T.-S; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 9 | 9 | |
2010 | Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 30 | 26 | |